We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eco Animal Health Group Plc | LSE:EAH | London | Ordinary Share | GB0032036807 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.50 | 9.04% | 102.50 | 100.00 | 105.00 | 102.50 | 97.00 | 97.00 | 73,747 | 10:04:10 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chem,fertlizer Minrl Mng,nec | 85.31M | 1.01M | 0.0149 | 67.45 | 68.08M |
From Apr 2019 to Apr 2024
TIDMEAH
RNS Number : 3173B
Eco Animal Health Group PLC
03 February 2020
3 February 2020
ECO Animal Health Group PLC
Total Voting Rights and Share Capital
ECO Animal Health Group PLC (the "Company") announces that the total number of ordinary shares of 5 pence each in the Company as at the date of this notice is 67,547,626. There are currently nil shares held in treasury.
The total number of voting rights in the Company is therefore 67,547,626. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules.
For further information, please contact:
ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO) 020 8447 6906 N+1 Singer (Nominated Adviser & Joint Broker) Mark Taylor Peter Steel Alex Bond 020 7496 3000 Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden 020 7418 8900 IFC Advisory Graham Herring Zach Cohen 020 3934 6630
About ECO Animal Health Ltd
ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin(R), as well as a range of generic therapeutic products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TVREAFFNALSEEFA
(END) Dow Jones Newswires
February 03, 2020 02:00 ET (07:00 GMT)
1 Year Eco Animal Health Chart |
1 Month Eco Animal Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
